OPTN Market Cap History



Below is a table of the OPTN market cap history going back to 10/13/2017:

Date OPTN Market Cap
10/13/2017672.34M
11/27/2017726.86M
3/1/2018663.41M
5/11/2018862.37M
8/3/2018881.30M
11/9/2018448.14M
3/1/2019328.05M
5/6/2019451.43M
8/9/2019214.64M
8/12/201983.81M
11/8/2019415.40M
5/1/2020191.89M
7/31/2020234.33M
10/30/2020166.66M
3/1/2021212.31M
4/30/2021189.61M
7/30/2021151.40M
10/31/2021141.64M
3/1/2022225.83M
5/6/2022178.59M
8/11/2022298.97M
10/31/2022291.49M
3/1/2023203.49M
5/1/2023199.28M
8/1/2023135.79M
11/1/2023139.83M
3/1/2024215.16M

Also see: OPTN Shares Outstanding History
and OPTN YTD Return
OPTN Historical Market Cap:
-16.34% CAGR
OPTN Historical Market Cap: +-16.34% CAGR

Mouse over chart for data details
10/13/2017 ...3/1/2024
OptiNose is a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists. Co.'s commercial product, XHANCE® (fluticasone propionate) nasal spray is a therapeutic utilizing its proprietary Exhalation Delivery System™ (EDS®) for the treatment of chronic rhinosinusitis with nasal polyps and. Co.'s solutions also include EDS, which enables the development of drug-device combination products intended for self-administration. Co. has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to provide drug deposition. We show 27 historical shares outstanding datapoints in our OPTN shares outstanding history coverage, used to compute OPTN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing OPTN market cap history over the course of time is important for investors interested in comparing OPTN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of OPTN versus a peer is one thing; comparing OPTN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like OPTN can fluctuate over the course of history. With this page we aim to empower investors researching OPTN by allowing them to research the OPTN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree OPTN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
OptiNose (OPTN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ORGO Market Cap History
ORGS Market Cap History
ORIC Market Cap History
ORMP Market Cap History
OSA Market Cap History
OSH Market Cap History
OSIR Market Cap History
OSUR Market Cap History
OTIC Market Cap History
OTLK Market Cap History
More Healthcare companies »

 

OPTN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.